Literature DB >> 6836332

Familial unconjugated hyperbilirubinemia syndromes.

J Reichen.   

Abstract

Our understanding of the biochemical defects underlying the hepatic forms of congenital, unconjugated hyperbilirubinemias has been greatly enhanced over the past decade. This is mostly due to the availability of pure, labeled bilirubin, the appropriate kinetic analyses, and a better understanding of the mechanisms underlying bilirubin conjugation. Although it is quite obvious that the defect underlying Gilbert's and Crigler-Najjar syndromes is deficient glucuronidation, the molecular explanation may eventually be found in altered composition of the microsomal lipids rather than in a protein defect of glucuronyl transferase. The recognition that Gilbert's syndrome is a quite heterogeneous entity will allow a better understanding of the mode of inheritance of this disorder; its relationship to Crigler-Najjar type II disease also awaits further definition. It is hoped that definition of the molecular defect in Crigler-Najjar type I will lead to better therapeutic modalities, but this remains to be seen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6836332     DOI: 10.1055/s-2008-1040668

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  3 in total

1.  Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia.

Authors:  Y Wakizaka; F Pan; A S Rao; S Celli; H Sun; T Miki; A J Demetris; J J Fung; T E Starzl; L A Valdivia
Journal:  Transplant Proc       Date:  1996-04       Impact factor: 1.066

Review 2.  Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.

Authors:  Siba El Hussein; Kenna R M Shaw; Francisco Vega
Journal:  Mod Pathol       Date:  2020-07-03       Impact factor: 7.842

3.  Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers.

Authors:  Yoshitaka Wakizaka; Toshio Miki; Abdul S Rao; Xue Wang; April L Goller; Anthony J Demetris; John J Fung; Thomas E Starzl; Luis A Valdivia
Journal:  Xenotransplantation       Date:  1997-11-01       Impact factor: 3.907

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.